For some Australians facing serious illness, the difference between treatment and going without can come down to cost—and instead of six figures…

Artificial intelligence may never replace a reassuring voice at the bedside, but it is already shaping the way Australians receive healthcare. From diagnostic algorithms to clinical decision support…

The report card on Australia’s mental health system has been released, and while there are glimmers of progress, the findings make clear that the system…

The importance of vaccines in preventing serious respiratory illness is no secret. But Sanofi’s recent $2.5 billion acquisition of Vicebio also marks a powerful signal of…

Living with more than one chronic condition is now a daily reality for nearly 40 per cent of Australians — and that number is expected to grow.

In a familiar blend of rhetoric and ambiguity, US President Donald Trump has again raised the prospect of imposing sweeping tariffs on foreign-made…

Every human body begins with a single cell. But how that cell divides, specialises and gives rise to the extraordinary complexity of tissues and organs has…

China is once again shifting gears in biotech. Under a new draft policy, the country’s drug regulator is proposing to halve its clinical trial review period for novel medicines—from 60 to just 30 working days.

When it comes to Aboriginal and Torres Strait Islander, progress is happening—but it’s not happening fast. That’s the key message from the latest Aboriginal and Torres Strait Islander Health Performance…

In a ground-breaking initiative, researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute), in collaboration with seven major Victorian hospitals, have successfully…

We often hear how overstretched Australia’s hospitals are. But what’s less often said is how many of those hospital stays may not have been necessary…

For all the talk of learning from COVID-19, global action has often lagged behind intent. That’s why the formal adoption of a new pandemic agreement…